Traditional distillation versus alternative purification processes
We are delighted to be holding a webinar on 6th June at 10am, reviewing recent changes to the European Pharmacopoeia Monograph and comparing the different approaches available for WFI production.
Recent changes to the European Pharmacopoeia Monograph have left many Pharmaceutical companies unclear as to which process to adopt in water for injection (WFI) production, as decision makers have the option of continuing with traditional methods or turning to newly approved techniques in providing pure distilled water for injections.
In the webinar, “Water for injection production with a Reverse Osmosis-based system”, James Steptoe, Business Development Manager at Veolia, will discuss how the European Pharmacopoeia Monograph has affected organisations in the market, compare distillation as the traditional method with the newly-approved RO technique and outline the advantages and disadvantages of both processes being used to provide WFI.
To join James Steptoe on 6th June at 10am register today.
© 2021 Veolia Water Technologies